Live from the NIH registry
Studies recruiting near Rock Hill right now
Top 25 of 610 recruiting studies, sorted by proximity — each links to its official registry page
Nephrotic Syndrome Study Network
Minimal Change Disease (MCD), Membranous Nephropathy
N/A
Observational 1,200 participants sought
Atrium Health Levine Children's Hospital — Charlotte, North Carolina (22.2 mi)
· Sponsor: University of Michigan
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Carolinas Medical Center/Levine Children's Hospital (Adults and Pediatrics) — Charlotte, North Carolina (22.2 mi)
· Sponsor: Pierre Fabre Medicament
Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients
Pediatric Cancer
Phase 2
Interventional 64 participants sought
Levine Cancer Institute — Charlotte, North Carolina (22.2 mi)
· Sponsor: Wake Forest University Health Sciences
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
Atrium Health — Charlotte, North Carolina (22.2 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
Chronic Lymphocytic Leukaemia, Moderate to Severe Cardiac Impairment
Phase 4
Interventional 60 participants sought
Research Site — Charlotte, North Carolina (22.2 mi)
· Sponsor: AstraZeneca
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Charlotte, North Carolina (22.2 mi)
· Sponsor: Sameek Roychowdhury
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 2
Interventional 224 participants sought
Monroe Biomedical Research — Monroe, North Carolina (27.0 mi)
· Sponsor: Genentech, Inc.
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Digestive Disease Associates — Rock Hill, South Carolina (1.2 mi)
· Sponsor: Janssen Research & Development, LLC
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Renal Cell Carcinoma
Phase 3
Interventional 904 participants sought
Carolina Oncology Specialists, PA ( Site 9002) — Charlotte, North Carolina (22.2 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
Severe Asthma
Phase 2
Interventional 512 participants sought
Research site — Rock Hill, South Carolina (1.2 mi)
· Sponsor: Kinaset Therapeutics Inc
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Carolina Cardiology Associates and OnSite Clinical Solutions — Rock Hill, South Carolina (1.2 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — Charlotte, North Carolina (22.2 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
Post Operative Surgical Site Infection
Phase 3
Interventional 600 participants sought
Atrium Health Carolinas Medical Center — Charlotte, North Carolina (22.2 mi)
· Sponsor: Major Extremity Trauma Research Consortium
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia (CLL)
Phase 2
Interventional 75 participants sought
Novant Health Presbyterian Medical Center /ID# 230201 — Charlotte, North Carolina (22.2 mi)
· Sponsor: AbbVie
Cephea Early Feasibility Study
Mitral Regurgitation
N/A
Interventional 90 participants sought
Atrium Health - Carolinas Medical Center — Charlotte, North Carolina (22.2 mi)
· Sponsor: Abbott Medical Devices
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Levine Cancer Institute-Rock Hill — Rock Hill, South Carolina (1.2 mi)
· Sponsor: NRG Oncology
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
Novant Health Cancer Institute — Charlotte, North Carolina (22.2 mi)
· Sponsor: Hoffmann-La Roche
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Refractory Angina
N/A
Interventional 380 participants sought
Novant Health — Charlotte, North Carolina (22.2 mi)
· Sponsor: Shockwave Medical, Inc.
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Carcinoma, Non-small-Cell Lung
Phase 2
Interventional 520 participants sought
Novant Health 1 — Charlotte, North Carolina (22.2 mi)
· Sponsor: Janssen Research & Development, LLC
Caring Connections Youth Suicide Detection and Intervention Study
Suicide, Suicide Prevention
N/A
Interventional 180 participants sought
The University of North Carolina at Charlotte — Charlotte, North Carolina (22.2 mi)
· Sponsor: University of North Carolina, Chapel Hill
The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study
Ischemic Heart Disease (IHD), Cardiac Magnetic Resonance Imaging
N/A
Interventional 1,000 participants sought
Atrium Health - Sanger Heart & Vascular Institute — Charlotte, North Carolina (22.2 mi)
· Sponsor: Brigham and Women's Hospital
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Transthyretin Amyloidosis With Cardiomyopathy
Phase 3
Interventional 1,750 participants sought
Clinical Trial Site — Charlotte, North Carolina (22.2 mi)
· Sponsor: Alnylam Pharmaceuticals
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
Delricht Clinical Research - Badmus — Charlotte, North Carolina (22.2 mi)
· Sponsor: Ardelyx
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Solid Tumor, Adult, Metastatic Solid Tumor
Phase 1
Interventional 130 participants sought
Atrium Health Carolinas Medical Center — Charlotte, North Carolina (22.2 mi)
· Sponsor: Sairopa B.V.
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10318, Charlotte, NC — Charlotte, North Carolina (22.2 mi)
· Sponsor: Colorado Prevention Center